|
Centene Corp. last week completed
its sale of pharmacy benefit manager MagellanRx to Prime
Therapeutics, the PBM jointly owned by 19 Blues affiliates. Centene first acquired
MagellanRx in January 2022, following its purchase of Magellan Health. The
company is also in the process of selling off another Magellan asset,
Magellan Specialty Health, to Evolent Health as it continues a value creation
plan spearheaded by CEO Sarah
London. Centene is currently the fourth-largest insurer in the U.S., serving
17,144,851 lives. |
No comments:
Post a Comment